Over expression of BCL2 and low expression of caspase 8 related to TRAIL resistance in brain cancer stem cells

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 12, 2015, Pages 4849-4852

  Qi, Ling ^a   Ren, Kuang ^a   Fang, Fang ^a   Zhao, Dong Hai ^a   Yang, Ning Jiang ^a   Li, Yan ^a  

^a JILIN MEDICAL COLLEGE   (China)

Author keywords

BCL2; Brain cancer stem cells; Caspase 8; TRAIL

Indexed keywords

CASPASE 8; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; BRAIN NEOPLASMS; CANCER STEM CELL; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CASPASE 8; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED;

EID: 84937035001     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.12.4849     Document Type: Article

References (18)

1. Bellail AC, Tse MC, Song JH, et al (2010). DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. J Cell Mol Med, 14, 1303-17.
2. Bellail AC, Olson JJ, Yang X, et al (2012). A20 ubiquitin ligasemediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov, 2, 140-55.
3. Capper D, Gaiser T, Hartmann C, et al (2009). Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation. Acta Neuropathol, 117, 445-56.
4. Ding LJ, Yuan CJ, Wei F, et al (2011). Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. Cancer Invest, 29, 511-520.
5. Dirks PB (2010). Brain cancer stem cells: the cancer stem cell hypothesis writ large. Mol Oncol, 4, 420-30.
6. Gao CM, Ding JH, Li SP, et al (2013). Polymorphisms in XRCC1 gene, alcohol drinking, and risk of colorectal cancer: a casecontrol study in Jiangsu Province of China. Asian Pac J Cancer Prev, 14, 6613-8.
7. Li YC, Tzeng CC, Song JH, et al (2006). Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clin Cancer Res, 12, 2716-29.
8. Li Z, Bao S, Wu Q, et al (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell, 15, 501-13.
9. Qi L, Bellail AC, Rossi MR, et al (2011a). Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis. Apoptosis, 16, 1150-64.
10. Qi L, Jin H, Ding LJ, et al (2011b). CD133 magnetic sorting and biological characteristics of brain cancer stem cells. Jo Jilin University (Medicine Edition), 37, 441-4.
11. Qi L, Yu HQ, Ding LJ, et al (2011c). Role of caspase-8 in glioblastoma resistance to TRAIL-induced apoptosis. J Jilin University (Medicine Edition), 37, 612-6.
12. Qi L, Jin H, Zhao DH, et al (2014). Effect of schisandra lignans on the apoptosis of SHG-44 glioma neurospheres. Chin Pharm J, 49, 113-6.
13. Qiu B, Wang Y, Tao J, et al (2012). Expression and correlation of Bcl-2 with pathological grades in human glioma stem cells. Oncol Rep, 28, 155-60.
14. Singh SK, Hawkins C, Clarke ID, et al (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401.
15. Wang R, Chadalavada K, Wilshire J, et al (2010). Glioblastoma stem-like cells give rise to tumour endothelium. Nature, 468, 829-33.
16. Yuan X, Curtin J, Xiong Y, et al (2004). Isolation of cancer stemcells from adult glioblastoma multiforme. Oncogene, 23, 9392-400.
17. Zhao XD, He YY, Gao J, et al (2014). High expression of bcl-2 protein predicts favorable outcome in non-small cell lung cancer: evidence from a systematic review and metaanalysis. Asian Pac J Cancer Prev, 15, 8861-9.
18. Zheng NG, Mo SJ, Li JP, et al (2014). Anti-CSC effects in human esophageal squamous cell carcinomas and eca109/9706 cells induced by nanoliposomal quercetin alone or combined with CD 133 antiserum. Asian Pac J Cancer Prev, 15, 8879-84.